Current Opinion and Knowledge on Peritoneal Carcinomatosis: A Survey among a Swiss Oncology Network

Autor: Michael Montemurro, Nicolas Demartines, David C. Martin, George Coukos, Martin Hübner, Anita Wolfer, Patrice Mathevet, Fabian Grass
Rok vydání: 2018
Předmět:
Male
medicine.medical_specialty
Peritoneal metastasis
MEDLINE
Antineoplastic Agents
03 medical and health sciences
0302 clinical medicine
Stomach Neoplasms
Interquartile range
Surveys and Questionnaires
Drug Discovery
medicine
Humans
Combined Modality Therapy
Pharmacology (medical)
030212 general & internal medicine
Peritoneal Neoplasms
Oncologists
Ovarian Neoplasms
Pharmacology
business.industry
Carcinoma
General Medicine
Peritoneal carcinomatosis
Infectious Diseases
Oncology
030220 oncology & carcinogenesis
Family medicine
Female
Hyperthermic intraperitoneal chemotherapy
Semantic differential
Colorectal Neoplasms
business
Antineoplastic Agents/therapeutic use
Carcinoma/diagnosis
Carcinoma/drug therapy
Carcinoma/secondary
Colorectal Neoplasms/pathology
Oncologists/psychology
Ovarian Neoplasms/pathology
Peritoneal Neoplasms/diagnosis
Peritoneal Neoplasms/drug therapy
Peritoneal Neoplasms/secondary
Stomach Neoplasms/pathology
Carcinomatosis
Opinion
Ovarian cancer
Satisfaction
Treatment
Qualitative research
Zdroj: Chemotherapy, vol. 63, no. 3, pp. 143-147
ISSN: 1421-9794
0009-3157
DOI: 10.1159/000488774
Popis: Aims of the Study: The present survey aimed to evaluate current opinion and practice regarding peritoneal metastasis (PM), satisfaction with available treatment options, and need for new therapeutic approaches. Methods: This was a qualitative study conducted between October 2016 and October 2017 in the Réseau Suisse Romand d’Oncologie including 101 members of various oncological specialties. Participants’ demographics, current practice, knowledge, and satisfaction regarding available treatment options and need for new treatment options were assessed by semantic differential scales through 33 closed questions with automatic reminders at 4-, 8-, 12-, and 16-week intervals. Results: Twenty-seven participants (27%) completed the survey. Participants were gastrointestinal or gynecologic oncologists and surgeons. Most participants (67%) evaluated their knowledge on PM as moderate, while 22% considered themselves as experts. Clinical usefulness of systemic chemotherapy and hyperthermic intraperitoneal chemotherapy was judged to be moderate to high for PM of ovarian and colorectal origin and moderate to poor for gastric origin. Satisfaction with available treatment options was 6/10 (interquartile range [IQR] 4–7) for ovarian, 5/10 (IQR 3–7) for colorectal, and 3/10 (IQR 1–3) for gastric PM. Treatment strategies varied widely for typical case vignettes. The need for new treatment modalities was rated as 8/10 (IQR 6–10). Conclusion: Usefulness of and satisfaction with available treatment options for PM were rated as moderate at best by oncological experts, and treatment strategies differed importantly among participants. There appears to be a clear need for standardization and new treatment modalities.
Databáze: OpenAIRE
Externí odkaz: